Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Voulgarelis

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Expert Review of Clinical Immunology|January 24, 2014
Predicting progression to lymphoma in Sjögren's syndrome patientsStavroula Giannouli, Michael Voulgarelis
Expert Review of Clinical Immunology|October 14, 2014
A comprehensive review of myelodysplastic syndrome patients with autoimmune diseasesStavroula Giannouli, Michael Voulgarelis
Mediators of Inflammation|September 28, 2010
Toll-like receptors, tissue injury, and tumourigenesisSavvas Ioannou, Michael Voulgarelis
Nature Reviews. Rheumatology|August 5, 2010
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndromeMichael Voulgarelis, Athanasios G Tzioufas
Rheumatic Diseases Clinics of North America|November 6, 2008
Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosisMichael Voulgarelis, Haralampos M Moutsopoulos
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Current Aspects of Pathogenesis in Sjögren's SyndromeMichael Voulgarelis, Athanasios G Tzioufas
Best Practice & Research. Clinical Rheumatology|December 11, 2007
Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasiasAthanasios G Tzioufas, Michael Voulgarelis
Clinical Reviews in Allergy & Immunology|November 10, 2007
Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patientsMichael Voulgarelis, Fotini N Skopouli
Current Opinion in Rheumatology|December 14, 2011
Myelodysplasia and autoimmunityStavroula Giannouli, Theoni Kanellopoulou, Michael Voulgarelis
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 29, 2013
MDR1 mRNA expression and MDR1 gene variants as predictors of response to chemotherapy in patients with acute myeloid leukaemia: a meta-analysisChrysoula Doxani, Michael Voulgarelis, Elias Zintzaras
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Expert Review of Clinical Immunology|January 24, 2014
Predicting progression to lymphoma in Sjögren's syndrome patientsStavroula Giannouli, Michael Voulgarelis
Expert Review of Clinical Immunology|October 14, 2014
A comprehensive review of myelodysplastic syndrome patients with autoimmune diseasesStavroula Giannouli, Michael Voulgarelis
Mediators of Inflammation|September 28, 2010
Toll-like receptors, tissue injury, and tumourigenesisSavvas Ioannou, Michael Voulgarelis
Nature Reviews. Rheumatology|August 5, 2010
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndromeMichael Voulgarelis, Athanasios G Tzioufas
Rheumatic Diseases Clinics of North America|November 6, 2008
Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosisMichael Voulgarelis, Haralampos M Moutsopoulos
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Current Aspects of Pathogenesis in Sjögren's SyndromeMichael Voulgarelis, Athanasios G Tzioufas
Best Practice & Research. Clinical Rheumatology|December 11, 2007
Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasiasAthanasios G Tzioufas, Michael Voulgarelis
Clinical Reviews in Allergy & Immunology|November 10, 2007
Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patientsMichael Voulgarelis, Fotini N Skopouli
Current Opinion in Rheumatology|December 14, 2011
Myelodysplasia and autoimmunityStavroula Giannouli, Theoni Kanellopoulou, Michael Voulgarelis
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 29, 2013
MDR1 mRNA expression and MDR1 gene variants as predictors of response to chemotherapy in patients with acute myeloid leukaemia: a meta-analysisChrysoula Doxani, Michael Voulgarelis, Elias Zintzaras
Pageof 8